Strong personal care and hospice growth is offset by expected near-term margin pressure and weak home health performance.
| Quarter | Q4 FY25 |
|---|---|
| Call date | 2026-02-25 |
| Length | 59 minutes |
| EPS | $1.57 |
| EPS consensus | $1.53 |
| Revenue | $373.1M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY26 · Q2 FY25
All ADUS earnings · Back to ADUS overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.